Bal Pharma Ltd Announces Q3 2025 Unaudited Standalone Financial Results

Bal Pharma Ltd has announced its unaudited standalone financial results for the quarter ended 31.12.2025. The total income for the quarter is Rs. 8,783.99 Lakhs, with revenue from operations being the major contributor at Rs. 8,749.48 Lakhs. The total expenses for the quarter stood at Rs. 8,689.37 Lakhs. The company reported a net profit of Rs. 194.62 Lakhs for the quarter. The earnings per share (EPS) for the quarter is Rs. 1.92. The company operates in the pharmaceuticals segment only.